Chemed Corporation (NYSE:CHE) Shares Acquired by Jericho Financial LLP

Jericho Financial LLP grew its stake in Chemed Corporation (NYSE:CHE - Free Report) by 14.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,802 shares of the company's stock after acquiring an additional 871 shares during the quarter. Chemed comprises approximately 3.0% of Jericho Financial LLP's portfolio, making the stock its 19th biggest holding. Jericho Financial LLP's holdings in Chemed were worth $4,185,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. MBE Wealth Management LLC purchased a new position in shares of Chemed during the first quarter valued at approximately $334,000. Synergy Asset Management LLC raised its holdings in Chemed by 108.4% in the 1st quarter. Synergy Asset Management LLC now owns 3,049 shares of the company's stock valued at $1,876,000 after acquiring an additional 1,586 shares during the last quarter. Cabot Wealth Management Inc. lifted its stake in shares of Chemed by 1.4% during the 1st quarter. Cabot Wealth Management Inc. now owns 23,750 shares of the company's stock worth $14,614,000 after purchasing an additional 329 shares during the period. Covea Finance boosted its holdings in shares of Chemed by 8.3% during the first quarter. Covea Finance now owns 6,500 shares of the company's stock worth $4,000,000 after purchasing an additional 500 shares during the last quarter. Finally, Blue Trust Inc. grew its position in shares of Chemed by 6.5% in the first quarter. Blue Trust Inc. now owns 1,645 shares of the company's stock valued at $1,012,000 after purchasing an additional 101 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank Of Canada increased their price objective on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th.

Insider Activity at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the sale, the executive vice president now directly owns 14,627 shares in the company, valued at $8,454,259.73. The trade was a 9.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,500 shares of company stock worth $3,213,780. Company insiders own 3.29% of the company's stock.

Chemed Stock Up 0.9%

Shares of NYSE CHE traded up $5.21 during trading on Tuesday, hitting $556.79. 95,394 shares of the company traded hands, compared to its average volume of 105,073. The firm has a market capitalization of $8.15 billion, a P/E ratio of 27.12, a P/E/G ratio of 2.29 and a beta of 0.54. The company has a 50-day moving average price of $566.00 and a 200-day moving average price of $564.77. Chemed Corporation has a 1 year low of $512.12 and a 1 year high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.20 earnings per share. Research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Investors of record on Thursday, May 29th were issued a $0.50 dividend. The ex-dividend date was Thursday, May 29th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed's payout ratio is 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.